ArticleCancers2020

Targeted-Alpha-Therapy Combining Astatine-211 and anti-CD138 Antibody in A Preclinical Syngeneic Mouse Model of Multiple Myeloma Minimal Residual Disease.

Sébastien Gouard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.